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Abstract
Background: The molecular genetics of the P blood group system and the absence of P1 antigen
in the p phenotype are still enigmatic. One theory proposes that the same gene encodes for both
the P1 and Pk glycosyltransferases, but no polymorphisms in the coding region of the Pk gene explain
the P1/P2 phenotypes. We investigated the potential regulatory regions up- and downstream of the
A4GALT (Pk) gene exons.
Results: P1 (n = 18) and P2 (n = 9) samples from donors of mainly Swedish descent were analysed
by direct sequencing of PCR-amplified 5'- and 3'-fragments surrounding the Pk coding region.
Seventy-eight P1 and P2 samples were investigated with PCR using allele-specific primers (ASP) for
two polymorphisms previously proposed as P2-related genetic markers (-551_-550insC, -160A>G).
Haplotype analysis of single nucleotide polymorphisms was also performed with PCR-ASP. In ~1.5
kbp of the 3'-untranslated region one new insertion and four new substitutions compared to a
GenBank sequence (AL049757) were found. In addition to the polymorphisms at positions -550
and -160, one insertion, two deletions and one substitution were found in ~1.0 kbp of the 5'-
upstream region. All 20 P2 samples investigated with PCR-ASP were homozygous for -550insC.
However, so were 18 of the 58 P1 samples investigated. Both the 20 P2 and the 18 P1 samples were
also homozygous for -160G.
Conclusion: The proposed P2-specific polymorphisms, -551_-550insC and -160G, found in P2
samples in a Japanese study were found here in homozygous form in both P1 and P2 donors. Since
P2 is the null allele in the P blood group system it is difficult to envision how these mutations would
cause the P2 phenotype. None of the novel polymorphisms reported in this study correlated with
P1/P2 status and the P1/p mystery remains unsolved.
Background
The P-related blood groups include four antigens that are
predominantly of glycolipid nature and occur in related
biosynthetic pathways [1].
The GLOB blood group system [International Society of
Blood Transfusion (ISBT) number 028] comprises the P
antigen and the GLOB collection (ISBT number 209)
includes the Pk antigen and also LKE that is not discussed
Published: 07 October 2005
BMC Genetics 2005, 6:49 doi:10.1186/1471-2156-6-49
Received: 28 March 2005
Accepted: 07 October 2005
This article is available from: http://www.biomedcentral.com/1471-2156/6/49
© 2005 Hellberg et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
Page 2 of 11
(page number not for citation purposes)
further here [2]. The P1 antigen is assigned to ISBT system
number 003. Five phenotypes depending on the presence
or absence of the three antigens, P1, P and Pk, are known
(Table 1). The presence of all three antigens results in the
P1 phenotype but absence of the P1 antigen causes the P2
phenotype. If both P1 and P are absent the phenotype P2
k
arises. Absence of P but presence of P1 and Pk results in the
P1
k phenotype. Absence of all three antigens results in the
p phenotype. In each of the phenotypes naturally occur-
ring-antibodies can arise against the missing antigen,
invariantly so in the case of P and Pk but less frequently for
P1. These phenotypes can be explained biochemically by
the presence or absence of some of the enzymes shown to
catalyse the pathways shown in Figure 1.
The P1 antigen is present on hematopoietic cells [3,4] and
other cells [5]. The strength of the antigen expression can
differ from one person to another and it seems to be
dependent on gene dosage [1]. Frequencies of the P1 phe-
notype vary in different ethnic groups, for example, ~80%
Table 1: The P/GLOB blood groups.
Phenotype Frequency Antigen present on RBC Antibodies in serum
P1 20–90%a P1, Pk, P none
P2 10–80%a Pk, P Anti-P1
pr a r e b none Anti-PP1Pk
P1
k rare P1, Pk Anti-P
P2
k rare Pk Anti-PP1
a These frequencies differ significantly between different populations. E.g. the frequency of P1 vs. P2 are virtually the opposite when Caucasians (80 
vs. 20%) and Japanese (20 vs 80%) are compared.
b While the frequency of this phenotype has been estimated at 1 per million, two population groups, Swedes and Amish people, have significantly 
higher numbers (e.g. 141 per million in Västerbotten county in Northern Sweden [21]).
Biosynthetic pathways relating the P1, P and Pk glycolipids Figure 1
Biosynthetic pathways relating the P1, P and Pk glycolipids.
Galα α α α4Galβ β β β4GlcCer
globotriaosylceramide
Galβ β β β4GlcCer
lactosylceramide
GlcNAcβ β β β3Galβ β β β4GlcCer
lactotriaosylceramide
Galβ β β β4GlcNAcβ β β β3Galβ β β β4GlcCer
paragloboside
Galα α α α4Galβ β β β4GlcNAcβ β β β3Galβ β β β4GlcCer
GalNAcβ β β β3Galα α α α4Galβ β β β4GlcCer
globoside
P1
P
α4GalT
α4GalT
Other pathways
Other pathways
Pk
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of Caucasians are P1, compared to only ~20% of Asians
[1]. This may be due to selective pressure since P1 and
related antigens can act as cellular receptors for microor-
ganisms and biotoxins [5].
Two genes that code for the Pk- and P-synthesizing
enzymes, 4-α-galactosyltransferase (α4GalT, Gb3 syn-
thase) [6] and 3-β-N-acetylgalactosaminyltransferase
(β3GalNAcT, globoside/Gb4 synthase) [7], respectively,
have been cloned. Subsequently, numerous mutations
have been found to explain the rare P1
k, P2
k [8,9] and p
[6,9-12] phenotypes.
The molecular genetic background of the P1 antigen
remains unknown. Several theories exist, including one
model suggesting that the same α4GalT is able to transfer
galactosyl residues to both lactosylceramide and paraglo-
boside but in order to use the latter as the acceptor, a reg-
ulatory protein is required [13]. Another model postulates
the existence of two different enzymes, and thus two
genes, requiring both of them to be inactivated to cause
the p phenotype [13]. A third model proposes a single
gene with three alleles, one allele coding for an α4GalT
that can utilise lactosylceramide and paragloboside as
acceptors, one allele using lactosylceramide only and the
third allele coding for an inactive form of the transferase
[14]. However, none of the known polymorphisms
(109A>G, 903G>C, 987G>A) in the coding region of the
Pk gene explains the P1/P2 phenotypes [6].
Recently, Iwamura et al. [15] suggested that transcrip-
tional regulation caused by two polymorphisms (-551_-
550insC, -160A>G) in the 5'-upstream region of the Pk
gene might be the reason for the P1/P2 phenotypes.
The Pk gene was originally thought to comprise two exons,
but recent GenBank depositions indicate the presence of
three exons with the whole coding region in exon 3, as
shown in Figure 2. Various publications have considered
different transcription starting points resulting in different
numbering of the same nucleotide positions. The num-
bers used here are described in the legend to Figure 2.
In this study we have investigated an extended sequence
surrounding the coding region of the Pk gene including
untranslated exons and intronic portions as well as poten-
tially regulatory regions 5' or 3'of the transcribed region.
Contrary to a previous report [15], we found no clear-cut
correlation with the P1/P2 phenotype, neither between
previously described polymorphisms in the 5'-regulatory
Schematic picture of the exon/intron structure of the A4GALT (Pk) gene and the positions of the 19 polymorphisms investigated Figure 2
Schematic picture of the exon/intron structure of the A4GALT (Pk) gene and the positions of the 19 polymor-
phisms investigated. The numbering systems used are as follows: The 5'-region and exon 1 are described using the same 
numbering as Iwamura et al. [15] for easy comparison. Intron 1 and exon 2 are numbered from the first nucleotide of each ele-
ment, with the number being preceded by int1- or ex2-, respectively. The adenosine of the translation start codon ATG in 
exon 3 is defined as nt. 1. Nucleotides upstream from this (untranslated exon 3 and the 3'-region of intron 2) are given as neg-
ative numbers. The exons are represented by rectangles and the intervening introns by triangles. Exons 1–3 are 21, 145 and 
1059 bp long, respectively and introns 1 and 2 are approximately 25 and 1.5 kbp long, respectively.
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region, nor any of the novel polymorphisms reported in
this study.
Results
Screening for the -551_-550insC and -160A>G 
polymorphisms by PCR-ASP
Seventy-eight samples were screened for the two genetic
markers previously [15] suggested to cause the P2 pheno-
type. The results are summarized in Table 2. Two haplo-
types, -550T;-160A and -551_-550insC;-160G, were
found whilst the other theoretically possible haplotypes,
550T;-160G and -551_-550insC;-160A, were not detected
in this study. Each of the 20 samples, that were pheno-
typed as P2 were homozygous for both -551_-550insC and
-160A>G, which could indicate that these polymorphic
positions were indeed P2-specific as proposed. However,
18 of the 58 P1  samples investigated were also
homozygous for the same polymorphic markers. Of the
remaining P1  samples, 32 were heterozygous at both
nucleotide positions and only eight samples were
homozygous for the proposed P1-specific combination, -
550T;-160A. Twenty-nine of the 32 heterozygous samples
were available for analysis by two haplotype-specific PCR
reactions (-550T;-160A and -551_-550insC;-160G). All
samples were positive in both PCR reactions, indicating
that the samples were heterozygous for the combinations
-550T;-160A and -551_-550insC;-160G and not for -
550T;-160G and -551_-550insC;-160A. Additionally, 26
samples with the rare phenotypes P1
k (n = 3), P2
k (n = 3)
and p (n = 20) were screened. One of the P1
k samples was
homozygous for the genetic markers reported to be asso-
ciated with the P2 phenotype, and the other two were het-
erozygous. Of the P2
k  samples two had the expected
polymorphisms (-551_-550insC;-160G), but the third P2
k
was heterozygous and thus the first reported sample that
lacks the P1 antigen in spite of a genotype not
homozygous for the -551_-550insC and -160G markers.
Sixteen of the 20 p samples were homozygous for -551_-
550insC;-160G, thus consistent with their lack of P1, but
one was heterozygous and three were homozygous for -
550T;160A. Due to lack of available DNA from these rare
individuals the haplotype-specific PCR was only run on
one of the four heterozygous samples. As above, this sam-
ple was also positive in both PCR reactions.
Amplification of the 5'-, 3'- and coding regions of the Pk 
gene for DNA sequencing
Ten of the 18 P1 samples with P2-associated polymor-
phisms (-551_-550insC;-160G) were chosen for further
investigation by sequencing the 5'-region and the 3'-
region, as were all eight P1(-550T;-160A) and nine of the
20 P2 samples. In three samples from each category the
whole Pk gene reading frame, located in exon 3, was also
sequenced.
In the 5'-region upstream of exon 1, four novel polymor-
phisms were detected compared to a sequence deposited
in GenBank (accession number AL049757). These
findings comprised a substitution (-770C>T), an insertion
(-107_-106insG) and two deletions (-907_-903del and -
17_8del). Interestingly, the latter deletion is located across
the border of the 5'-region and exon 1.
In the 3'-UTR, five new polymorphisms were found, four
of which were substitutions (1409G>A, 1495C>A,
1523G>A, 1697G>A) and one was an insertion
(1592dupG). Figure 2 shows the relative positions of the
polymorphisms investigated.
The distribution of the polymorphisms in the three differ-
ent categories, P1(-550T;-160A), P1(-551_-550insC;-
160G) and P2 are shown in Figure 3. As can be seen, none
of the polymorphisms is a genetic marker specific for the
P2 phenotype. On the other hand, individuals from the
P1(-550T;-160A) category are homozygous for 12 of the
16 investigated polymorphisms. However, when individ-
uals from the P1(-551_-550insC;-160G) samples are
included such pattern is no longer evident. It can also be
noted that the frequency of some of the variants appears
Table 2: The occurrence of the -550T;-160A and -551_-550insC;-160G haplotypes in individuals with various P phenotypes.
Combination of polymorphisms
Phenotype No. -550T;-160A (homozygous) -550T;-160A -
551_550insC;-160G 
(heterozygous)
-551_-550insC;-160G 
(homozygous)
P1 58 8 32 18
P2 20 0 0 20
P1
k 3021
P2
k 3012
p2 03 11 6BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
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The distribution of the polymorphic variants in the three different sample categories: P1(-550T;-160A), P1(-551_-550insC;- 160G) and P2 Figure 3
The distribution of the polymorphic variants in the three different sample categories: P1(-550T;-160A), P1(-
551_-550insC;-160G) and P2. The diagram shows data of 16 polymorphisms investigated. The data for the 5'- and the 3'-
regions were obtained by sequencing while most of the data for exon 3 originated from PCR-ASP analysis. Eight, P1(-550T;-
160A), ten P1(-551_-550insC;-160G) and nine P2 samples were investigated. However, for the 903C>G polymorphism the 
corresponding numbers were five, five and seven samples. In position -107_-106 all investigated samples had three guanosines 
instead of two as reported in the reference sequence (AL049757). We therefore do not consider this position as polymorphic 
in our analysis and it is consequently not included in this figure. cons. = consensus.
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to be relatively low, less than ~10 %, for six of the poly-
morphic sites analyzed.
While sequencing exon 3, an unexpected mutation,
441G>A, was encountered in a P1 sample of African ori-
gin. No other samples, including two of African descent,
examined in this study had this particular mutation,
which would not alter the amino acid sequence, or any
other new polymorphisms.
Haplotype analysis of SNPs in the reading frame and a 
polymorphism in the 3'-UTR using PCR-ASP
We also performed PCR-ASP utilising polymorphisms in
exon 3 and in the 3'-UTR of the Pk gene to determine the
cis/trans linkage of SNPs and to establish if combinations
of polymorphisms correlated with specific alleles. The
SNPs chosen were two of those previously described, i.e.
109A>G and 987G>A. Analysis of the polymorphism
903C>G was considered unnecessary due to its proximity
to nt. 987. In addition, of the new polymorphisms the one
furthest downstream (1697G>A) was analyzed. The
results are summarized in Table 3. None of the haplotypes
correlated well with the P1/P2 phenotypes although 83%
of the alleles among the P2 samples and 75% of the P1(-
551_-550insC;-160G) category samples had the A-1 hap-
lotype, whilst in the P1(-550T;-160A) category samples
only 12.5% had this partial haplotype (B-1). The remain-
ing alleles in this latter category consisted of 12.5% of the
rare B-3 and 75% of the B-2 haplotype.
Discussion
The molecular background of the P blood group system
has been a subject of speculation since its discovery. Anti-
gens formed as a result of closely related biosynthetic
pathways are now known to arise from independent
genetic loci. However, the current paradox revolves
around the 4-α-galactosyltransferase (α4GalT) that syn-
thesises the Pk antigen and possibly also the P1 antigen. If
it is indeed exactly the same enzyme synthesizing both,
then the P2 and P2
k phenotypes should not exist, as the P1-
synthesizing α4GalT that is lacking in these individuals
should also result in the loss of the Pk and, subsequently,
P antigens. The absence of the P1 antigen is not due to a
defect in the biosynthesis of paragloboside since this gly-
colipid is a major precursor of the erythrocyte ABH anti-
gens that are unaffected by the P1/P2 status. The absence of
P1 antigen in the P2 phenotype is likely to be caused by
inefficient or absent glycosyltransferase activity that can
be due to a structural defect in the enzyme itself or more
indirectly due to various other factors necessary to ensure
the enzyme's optimal expression, localisation and effi-
ciency[1]. Studies are currently in progress to analyse
A4GALT mRNA by real-time PCR and other methods.
The P1 and Pk antigens both share the same terminal car-
bohydrate structure and therefore the question arises
whether the same enzyme is, or is not, synthesizing both
antigens. Various theories exist but so far none has been
proven correct. Recently Iwamura et al [15] proposed that
the P1 synthase is identical to the Pk synthase and that the
phenotypic difference may be caused by two polymor-
phisms, -160A>G and -551_-550insC, found in the 5'-
upstream regulatory region. Unfortunately, these authors
were not able to show any functional effects of these two
polymorphisms, at least not when tested in a fibroblast
cell line. As they commented themselves, a haematopoi-
etic cell line, preferentially even an erythropoietic one,
would have been the optimal choice for the challenge but
was technically difficult. Iwamura et al. also demonstrated
the presence of cryptic and intracellular P1 antigen in cells
from individuals known to have the P2 red blood cell phe-
notype. Whether this surprising finding is method-
dependent or may differ between populations is currently
unclear.
Table 3: Correlation of phenotype and haplotype
Phenotype No. of 
samples
Polymorphism Haplotype No. of 
haplotypes
-550 -160 109 987 1697
P1 10 insC G A G G A-1 15
insC G G A A A-2 5
P1 8T A A G G B - 1 2
TA G A A B - 2 1 2
TA G A G B - 3 2
P2 9i n s C G A G G A - 1 1 5
insC G G A A A-2 3BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
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Our data indicate that an individual's P1/P2 status is not
due to the -551_-550insC;-160G haplotype, contrary to
the previously published indication [15]. However, it is
striking that all (except one P2
k) samples with the P2 phe-
notype tested here have the same -551_-550insC;-160G
haplotype as all ten P2 samples tested by Iwamura et al.
This clearly argues that the genetic linkage between the
A4GALT locus and P2 status must be relatively strong. The
results shown in Figure 3 indicate that none of the 16 pol-
ymorphic markers investigated can predict the serologi-
cally determined P1/P2 status. It is also interesting to note
the high frequency with which SNPs occur in the A4GALT
gene, as opposed to the gene coding for the next glycosyl-
transferase in this biosynthetic pathway, the P synthase, in
which we have found no variations at all. The only excep-
tions are rare mutations causing the P1
k and P2
k pheno-
types [8,9]. Despite the apparent variability in the
A4GALT gene, the current study suggests that a limited
number of haplotypes, with the A-1 and B-2 haplotypes
being the predominant ones in the Swedish population,
may constitute genetic clusters within which further vari-
ation has arisen (as judged by the lack of homogeneity
within each group, see Table 3), still without obvious cor-
relation to the blood group phenotype.
However, all this does not differentiate between the one-
gene theory and the possibility of a tightly coupled inde-
pendent locus responsible for P1 antigen expression.
Since there are no apparent α4GalT homologues in this
genetic region this may imply that a hypothetical second
closely linked gene would give rise to either a regulatory
molecule modifying the acceptor specificity of the Pk-syn-
thesizing α4GalT (analogous to lactose synthetase [16]) or
a chaperone type of molecule to make a fraction of the
α4GalT molecules more suitably located/positioned for
P1 synthesis. The finding of intracellular P1 antigen in P2
individuals [15], would tend to support the latter possibil-
ity. Chaperones have been shown to be involved in proc-
esses related to glycosyltransferase action [17] but it is
somewhat difficult (although not impossible) to imagine
an α4GalT-specific chaperone to be the solution for this
long-standing enigma.
Conclusion
The study of potential regulatory regions surrounding the
Pk coding sequence revealed nine previously unreported
polymorphisms but none of them correlated with the P1/
P2  red blood cell phenotypes. Two polymorphisms, -
551_-550insC and-160A>G, suggested to cause the P2
phenotype in Japanese individuals [15] were found in
homozygous form also in P1 samples in this study and
since the P2 is the null phenotype of this blood group sys-
tem, it is therefore very unlikely that these mutations
cause the P2 phenotype.
Methods
Blood samples and DNA preparation
Samples with the P1 (n = 58) and P2 (n = 20) phenotypes
were chosen from our in-house panel of test erythrocytes.
The majority of the donors are of Swedish origin but a few
are of Asian or African descent. Three P1
k, three P2
k and 20
p samples, genetically characterized in our laboratory,
were also included for screening purposes [8,9,12,18].
The erythrocyte phenotype was determined by standard
serological techniques.
DNA was prepared from EDTA blood using a simple salt-
ing-out method for small volumes modified from Miller
et al. [19], or Qiagen QIAmp Blood Extraction kit (Qiagen
GmbH, Hilden, Germany). The DNA was dissolved in
H2O at a concentration of 100 ng/µl.
Screening for the -551_-550insC and -160A>G 
polymorphisms by PCR-ASP
All oligonucleotide primers used in the study were synthe-
sized by DNA Technology ApS (Aarhus, Denmark) and
the sequences are shown in Table 4. PCR with allele-spe-
cific primers designed to detect the polymorphisms at -
551_-550insC and -160A>T, described to cause the P2
phenotype [15] was performed. For all heterozygous sam-
ples double allele-specific amplification, -551_-550insC;-
160G and -550T;160A, were performed. The primer com-
binations used are listed in Table 5 and the locations in
Figure 4. Primers were mixed with 100 ng of genomic
DNA, 2 nmol of each dNTP, 2% glycerol, 1% cresol red
and 0.5 U of AmpliTaq Gold (Perkin Elmer/Roche Molec-
ular Systems, Branchburg, NJ, USA) in 10 × PCR buffer
with 15 mM MgCl2. The final reaction volume was 11 µl.
Thermocycling was undertaken in GeneAmp PCR system
2400/2700 (Perkin-Elmer/Cetus, Norwalk, CT, USA)
under PCR conditions described in Table 5.
Amplification of the 5'-, 3'- and coding regions of the Pk 
gene for DNA sequencing
The coding region, exon 3, in the Pk gene was amplified
with the primer pair Pk-(-140)-F and Pk-1120-R in the
Expand High Fidelity PCR System (Roche Molecular Sys-
tems, Pleasanton, CA, USA) and sequenced as previously
described [12].
The 5'-regulatory region of the Pk gene was amplified with
primers Pk-5'-(-1056)-F and Pk-int1-160-R and Pk-5'-(-
131)-F and Pk-int1-160-R. Amplification was performed
in a reaction volume of 22 µL with four pmol of each
primer, 2 nmol of each dNTP, 100 ng of genomic DNA,
GC-rich enzyme mix (0.5 U per reaction), GC-rich resolu-
tion solution and buffer with a final MgCl2 concentration
of 1.5 mM (GC-rich PCR System, Roche Diagnostics
GmbH, Mannheim, Germany). Thermocycling was
undertaken in GeneAmp PCR system 2400/2700 (Perkin-BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
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Elmer/Cetus): Initial denaturation at 96°C for 7 min fol-
lowed by 10 cycles at 94°C for 30 s, 62°C for 30 s and
72°C for 1 min and then 25 cycles at 94°C for 30 s, 60°C
for 30 s and 72°C for 1 min.
For the 3'-region of the Pk gene 5 pmol of primers Pk-
(1006)-F and Pk-(1881)-R were mixed with 100 ng of
genomic DNA, 2 nmol of each dNTP, 2% glycerol, 1%
cresol red and 0.5 U of AmpliTaq Gold (Perkin Elmer/
Roche Molecular Systems) in 10 × PCR buffer with 15 mM
MgCl2. The final reaction volume was 11 µl. PCR was run
at 96°C for 7 min followed by 35 cycles at 94°C for 30 s,
64°C for 30 s and 72°C for 1 min.
PCR products were excised from 3% agarose gels (Seakem,
FMC Bioproducts, Rockland, ME, USA) stained with
ethidium bromide (0.56 mg/l gel, Sigma Chemicals, St.
Louis, MO, USA) following high-voltage electrophoresis
and purified using Qiaquick gel extraction kit (Qiagen).
The Big Dye Terminator Cycle Sequencing kit (Applied
Biosystems, Foster City, CA, USA) and an ABI PRISM 310
Genetic Analyser (Applied Biosystems) were used for
Table 4: Oligonucleotide primers used in this study.
Primer name Nucleotide sequence (5'→3') Function
Pk-5'-(-1056)-F† ACAGCCTGTGATGGGAATGAC a, b, e
Pk-5'-(-740)-R† TTGAGTGCTGACGCCCATCC b
Pk-5'-(-834)-F TGGGCACCCATTGAGTGCCA b, e
Pk-5'-(-550)-R ACCTCGCCCCATCTTCACAC e
Pk-5'-(550T)-F GAACAAATTACCAATAGCAATATGT e
Pk-5'-(-550insC)-R CCTCGCCCCATCTTCACAGC e
Pk-5'-(550insC)-F AACAAATTACCAATAGCAATATGCT e
Pk-5'-(-477)-F GCGGCGTTAAGGATACAGCAA b
Pk-5'-(-418)-R CTGATCCCACCGCCTCCTG b
Pk-5'-(-235)-F GCGCTCCCTACCTGTTGGC b
Pk-5'-(-131)-F GGACCGGGACCCGCAGGG a, b
Pk-5'-(-160Gmis)-R CCCGGTCCCCAGAGCACC e
Pk-5'-(-160Amis)-R CCCGGTCCCCAGAGCACT e
Pk-5'-(-160G)-R CCGGTCCCCAGAGCCCTC e
Pk-5'-(-160A)-R CCCGGTCCCCAGAGCCCTT e
Pk-int1-35-R CGTCCCCCGCAACATCGGC b
Pk-int1-160-R GCACAAATGTCGCCTCCAGAA a, b
Pk-ex2-74_75insC-F AGGTCGGCTGCTGAGCCCA e
Pk-int2-R GGGTGCAACCTGATTGCTAAG e
Pk-109G-F TTCACGTTTTTCGTCTCCATCG e
Pk-109A-F TTCACGTTTTTCGTCTCCATCA e
Pk-987G-F CACGCGGTTCGAGGCCACG e
Pk-987A-F CACGCGGTTCGAGGCCACA e
Pk-1120-R GGAAGGGCGGCCCAGTGC e
Pk-1006-F CCAGGGCACTGCTGGCCC c, d
Pk-1253-F GGACAGTGTCCTGTCTCGAG d
Pk-1697G-R CCTGTCTGAGGGAAGGGGC e
Pk-1697A-R CCCTGTCTGAGGGAAGGGGT e
Pk-1791-R TTATTCTATTGATTATTCTCCTGTG d
Pk-1881-R CCCCGTCAGAAGAATGGAGC c, d
HGH-F TGCCTTCCCAACCATTCCCTTA f
HGH-R CCACTCACGGATTTCTGTTGTGTTTC f
JK-781-L-F GCATGCTGCCATAGGATCATTGC f
JK-943-L-R GAGCCAGGAGGTGGGTTTGCC f
MO-21 GGTGAGAGAAGGAGGGTGAG f
MO-31 CCAGCACCCCGGCCAGCA f
† F = Forward. R = Reverse. The underlined nucleotide is mismatched for better specificity.
a. used for amplification of the 5' regulatory region.
b. used for sequencing of the 5' regulatory region.
c. used for amplification of the 3'-UTR.
d. used for sequencing the 3'-UTR.
e. used for PCR-ASP.
f. used as internal control.BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
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direct DNA sequencing with capillary electrophoresis and
automated fluorescence-based detection according to the
manufacturer's instructions. Besides the PCR primers,
internal primers were used as sequencing primers, see
Table 4. To avoid detection of artefacts, sequencing was
performed on both strands and using independently
obtained fragments.
Detection of an insertion in exon 2 and linkage of SNPs in 
the reading frame with a polymorphism in the 3'-UTR 
using PCR-ASP
PCR-ASP for a previously found insertion, 75dupC in
exon 2 (then believed to be exon 1), was also performed
as described [12]. PCR-ASP was performed to investigate
if the polymorphisms at nt. 109, 987 and 1697 were
present in an allele-specific pattern. The reaction mixtures
comprised 100 ng of genomic DNA, 2 nmol of each
dNTP, 2% glycerol, 1% cresol red and 0.5 U of AmpliTaq
Table 5: Oligonucleotide primer combinations and PCR conditions (previously not described) used for PCR-ASP in this study.
Primer 
combination
Specific primer 
(pmol)
Control primer DMSO (%) Annealing 
temperature 
(°C)
Extension time 
(sec)
HGH-F/R 
(pmol)
JK-L-F/R (pmol) MO-21/31 
(pmol)
Pk-5'-(-1056)-F 5 1 64 40
Pk-5'-(-550)-R 5
Pk-5'-(-1056)F 5 1 64 40
Pk-5'-(-
550insC)-R
5
Pk-5'-(-834)-F 7.5 0.5 4 62 60
Pk-5'-(-160A-
mis)-R
7.5
Pk-5'-(-834)-F 5 0.5 3 62 60
Pk-5'-(-160G-
mis)-R
5
Pk-5'(-
550insC)-F
10 0.75 64 40
Pk-5'-(-160G)-R 10 0.75
Pk-5'(-550T)-F 7.5 0.5 63 40
Pk-5'-(-160A)-R 7.5 0.5
Pk-109A-F or 
Pk-109G-F
6 0.4 2 65 90
Pk-1697A-R or 
Pk-1697G-R*
6
Pk-987A-F 5 0.4 66 60
Pk-1697A-R 5
Pk-987G-F 5 0.4 66 60
Pk-1697G-R 5
Pk-109A-F or 
Pk-109G-F
7.5 0.5 64 60
Pk-1120-R**
Denaturation was carried out at 96°C for 7 min followed by 35 cycles at 94°C for 30 s. The annealing time was 30 s.
* Four double allele-specific amplifications were performed.
** These combinations were used for allele-specific amplifications for sequencing purposes.BMC Genetics 2005, 6:49 http://www.biomedcentral.com/1471-2156/6/49
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Gold (Perkin Elmer/Roche Molecular Systems) in 10 ×
PCR buffer with 15 mM MgCl2. The final reaction volume
was 11 µl. Primer combinations and PCR conditions are
described in Figure 4 and Table 5.
List of abbreviations
ASP, allele specific primer
bp, base pairs
ins, insertion
del, deletion
kb, kilo bases
PCR, polymerase chain reaction
SNP, single nucleotide polymorphism
UTR, untranslated region
ISBT, International Society of Blood Transfusion.
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